Bioengineered, 2022 · DOI: https://doi.org/10.1080/21655979.2022.2068737 · Published: April 14, 2022
Spinal cord injury (SCI) often leads to permanent nerve damage. Astrocytes, important brain cells, become active after SCI, leading to cell growth and scar formation, which can prevent nerve repair. The study explores the TWEAK/NF-κB pathway's role in SCI. It suggests that this pathway promotes SCI by activating astrocytes. The study aimed to find new ways to treat spinal cord injury. The researchers found that blocking TWEAK and NF-κB reduced inflammation and promoted nerve growth. This suggests that the TWEAK/NF-κB pathway could be a target for new SCI treatments.
The TWEAK/NF-κB pathway is identified as a potential therapeutic target for SCI treatment.
Inhibiting this pathway may reduce inflammation and promote nerve regeneration.
Modulating astrocyte activity through the TWEAK/NF-κB pathway could improve outcomes after SCI.